Long-term Outcomes with Ambrisentan Monotherapy in Pulmonary Arterial Hypertension

INTRODUCTION: This study evaluated long-term outcomes in patients with pulmonary arterial hypertension (PAH) undergoing treatment with ambrisentan monotherapy, a selective oral endothelin-1 receptor antagonist. METHODS: Patients who participated in the ARIES-1 clinical trial and extension phase at o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Blalock, SE, Matulevicius, S, Mitchell, LC, Reimold, S, Warner, J, Peshock, R, Torres, F, Chin, KM
Formato: Artigo
Lenguaje:Inglês
Publicado: 2009
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2819977/
https://ncbi.nlm.nih.gov/pubmed/20142023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cardfail.2009.09.008
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares